On Thursday, Novavax published positive trial data, saying that its coronavirus vaccine candidate was ‘safe’ and ‘elected an immune response. This come as Sanofi and GlaxoSmithKline announced that they would start phase 1/2 of their adjuvanted vaccine. Yahoo Finance’s Anjalee Khemlani breaks down the latest news about the coronavirus on The Final Round.
